Home LiteratureArticle Details
PMID: 15492259 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Growth promoting signaling by tenascin-C [corrected].

Cancer research ·Vol. 64 ·No. 20 ·2004-10-15 ·Pages 7377-85

Ruiz C, Huang W, Hegi ME, Lange K, Hamou MF, Fluri E, Oakeley EJ, Chiquet-Ehrismann R, Orend G

Abstract

Tenascin-C is an adhesion-modulating extracellular matrix molecule that is highly expressed in tumor stroma and stimulates tumor cell proliferation. Adhesion of T98G glioblastoma cells to a fibronectin substratum is inhibited by tenascin-C. To address the mechanism of action, we performed a RNA expression analysis of T89G cells grown in the presence or absence of tenascin-C and found that tenascin-C down-regulates tropomyosin-1. Upon overexpression of tropomyosin-1, cell spreading on a fibronectin/tenascin-C substratum was restored, indicating that tenascin-C destabilizes actin stress fibers through down-regulation of tropomyosin-1. Tenascin-C also increased the expression of the endothelin receptor type A and stimulated the corresponding mitogen-activated protein kinase signaling pathway, which triggers extracellular signal-regulated kinase 1/2 phosphorylation and c-Fos expression. Tenascin-C additionally caused down-regulation of the Wnt inhibitor Dickkopf 1. In consequence, Wnt signaling was enhanced through stabilization of beta-catenin and stimulated the expression of the beta-catenin target Id2. Finally, our in vivo data derived from astrocytoma tissue arrays link increased tenascin-C and Id2 expression with high malignancy. Because increased endothelin and Wnt signaling, as well as reduced tropomyosin-1 expression, are closely linked to transformation and tumorigenesis, we suggest that tenascin-C specifically modulates these signaling pathways to enhance proliferation of glioma cells.

MeSH Terms
Actins/metabolism Cell Growth Processes/drug effects Cell Line, Tumor Cytoskeletal Proteins/biosynthesis,genetics DNA-Binding Proteins/biosynthesis,genetics Down-Regulation/drug effects Gene Expression Profiling Gene Expression Regulation, Neoplastic/drug effects Glioblastoma/genetics,metabolism,pathology Humans Inhibitor of Differentiation Protein 2 MAP Kinase Signaling System/drug effects Proto-Oncogene Proteins/physiology RNA, Messenger/biosynthesis,genetics Repressor Proteins/biosynthesis,genetics Signal Transduction/drug effects Tenascin/pharmacology Transcription Factors/biosynthesis,genetics Tropomyosin/biosynthesis Wnt Proteins
Chemicals
Actins Cytoskeletal Proteins DNA-Binding Proteins ID2 protein, human Inhibitor of Differentiation Protein 2 Proto-Oncogene Proteins RNA, Messenger Repressor Proteins TPM1 protein, human Tenascin Transcription Factors Tropomyosin Wnt Proteins
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Ruiz Christian
Friedrich Miescher Institute for Biomedical Research, Novartis Forschungsstiftung, Basel, Switzerland.
Huang Wentao
Hegi Monika E
Lange Katrin
Hamou Marie-France
Fluri Erika
Oakeley Edward J
Chiquet-Ehrismann Ruth
Orend Gertraud
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
2004-10-15
Pages
7377-85
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com